EMJ Microbiology & Infectious Diseases 2.1 2021

Welcome to the latest issue of EMJ Microbiology & Infectious Diseases! Included is an impressive collection of the latest research in this specialty, alongside our review of the 31^st annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) Highlights, interviews, and breaking news from this virtual event are shared in this issue.

Assessing CBNAAT for Extrapulmonary Tuberculosis Diagnosis: A Retrospective Study

Tuberculosis (TB) represents a significant global public health issue, ranking as the 13th leading cause of mortality and standing as the… Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to rate this content.

Adverse Drug Events from First-Line Anti-tuberculosis Drugs

Tuberculosis (TB) is caused by the bacteria Mycobacterium tuberculosis, a complex, rod-shaped, non-spore-forming, thin, aerobic bacterium… Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to rate this content.

Challenges of Unpredictability: Meningitis Prevention

In this informative interview article, expert Federico Martinón-Torres discusses the unpredictability of meningitis and the challenges in preventing, diagnosing, and treating this rare infectious disease. Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to rate this content.

Battling Pediatric Mold Infections: Invasive Aspergillosis and Invasive Mucormycosis

Mold species are inhaled by people every day and, typically, infection is locally curtailed by the immune system. However, in people who… Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to rate this content.

EMJ Microbiology & Infectious Diseases 2.1 2021

In this issue

Assessing CBNAAT for Extrapulmonary Tuberculosis Diagnosis: A Retrospective Study

Adverse Drug Events from First-Line Anti-tuberculosis Drugs

Challenges of Unpredictability: Meningitis Prevention

Battling Pediatric Mold Infections: Invasive Aspergillosis and Invasive Mucormycosis

Therapy Area

About Us

EMJ Microbiology & Infectious Diseases 2.1 2021

In this issue

Latest articles

Assessing CBNAAT for Extrapulmonary Tuberculosis Diagnosis: A Retrospective Study

Adverse Drug Events from First-Line Anti-tuberculosis Drugs

Challenges of Unpredictability: Meningitis Prevention

Battling Pediatric Mold Infections: Invasive Aspergillosis and Invasive Mucormycosis